Additional file 1 of Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)

Supplementary Material Table S1: The 65 PT entries that simultaneously satisfied the four methods of disproportionality analysis with positive signal strength in FAERS. The PT entries are categorized into three groups: expected with signal (unmarked), disease-expected (marked with +), and unexpected (marked with *), and are listed in descending order of case number.